TransCode Therapeutics (NASDAQ:RNAZ) on Wednesday announced the closing of its previously announced public offering of 10M shares of its common stock at $0.30 per share, for gross proceeds of $3M. The...
Source LinkTransCode Therapeutics (NASDAQ:RNAZ) on Wednesday announced the closing of its previously announced public offering of 10M shares of its common stock at $0.30 per share, for gross proceeds of $3M. The...
Source Link
Comments